Corewell Health the Michigan Cancer Consortium — Grand Rapids, Michigan

Corewell Health the Michigan Cancer Consortium is a clinical research site located in Grand Rapids, Michigan, United States 49503-2560.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Corewell Health the Michigan Cancer Consortium has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Relapsed/Refractory Follicular Lymphoma, Marginal Zone Lymphoma.

Sponsors: BeiGene.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Corewell Health the Michigan Cancer Consortium?

Corewell Health the Michigan Cancer Consortium has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Corewell Health the Michigan Cancer Consortium conducted?

Corewell Health the Michigan Cancer Consortium has 1 clinical trials on record, with 1 currently active. Their work covers Relapsed/Refractory Follicular Lymphoma, Marginal Zone Lymphoma.

Is Corewell Health the Michigan Cancer Consortium accredited by Crixeo Health?

Corewell Health the Michigan Cancer Consortium has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Corewell Health the Michigan Cancer Consortium?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.